| Name | Title | Contact Details |
|---|
For 25 years, Q'Straint has remained focused on one vision: to develop the world's most effective wheelchair passenger safety solutions for public and private transportation. Today, Q'Straint is a global company with a local network of representatives
Modern Medical Systems is a Farmingdale, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sunrise Labs architects and implements innovative engineering solutions for ‘smart’ products that work. We are a product development company specializing in one-stop delivery of robust, reliable medical devices and industrial instrumentation.Eric, Laurin and Drew In 1992, Drew Sunstein founded our company to partner with clients and produce quality, practical, cost-effective design solutions with a sharp focus on time-to-market. We build products that work. Our products work for the end user, the manufacturer, and all service providers. With experience spanning the development progression, and a reputation for delivering on commitments, our team is the smart choice to tackle your product development challenges. Our engineers design quality in by fully understanding the requirements before designing or coding begins. Our ISO 9001 and ISO 13485 certified processes are built to stand alone or work in adjunct to your quality systems. Our facilities, services, and systems are flexible, allowing us to scale our efforts to support your needs and maximize efficiency. We honor our commitments and stand behind our engineering. From idea to implementation, we build innovative engineering solutions that result in “smart” products that work.
Entech Supply is a Anderson, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.